Cops bust inter-state pharma drug cartel, nab 5

The Delhi Police have busted an inter-state cartel operating across Delhi, Uttar Pradesh and Himachal Pradesh, arresting five key traffickers and seizing over 32,000 tablets of controlled substances, an official said on Tuesday.

The team apprehended the accused in a series of raids and seized 18,000 Tramadol tablets (1.8 kg); 7,380 Tramadol capsules (369 grams); 7,400 Nitrazepam tablets (Elza-10); and 505 Alprazolam tablets, with an estimated international market value of over Rs 5 lakh.

The police also seized Rs 1.85 lakh from them, said the official. The arrested accused have been identified as Sudhir (43), Vikas (20), Sunil Kumar Bhardwaj (50), Ajeet Kumar (32) and Ambar Agrahari (43).

According to the police, Sudhir is a repeat offender from Haryana and was earlier arrested by Punjab Police in a similar Narcotic Drugs and Psychotropic Substances (NDPS) case in 2019. Police said Sudhir resumed trafficking after his release in 2024. He partnered with Sunil Kumar Bhardwaj in operating two medical stores in Delhi. Bhardwaj, who was linked to the earlier NDPS case along with Sudhir, played a pivotal role in managing trafficking operations and sourcing drugs.

Ajeet Kumar, an MBA graduate and a former pharmaceutical company employee, acted as the key conduit between Gorakhpur suppliers and Delhi markets. Agrahari, son of a wholesale medicine dealer in Gorakhpur, supplied the drugs from Uttar Pradesh and coordinated deliveries through inter-state buses. He was arrested from a hotel in Delhi’s Paharganj, police said.

The case also led to the identification of Vijay Goel, currently lodged in Agra jail in another NDPS case, as a past supplier of Nitrazepam, the officer said.

  • Related Posts

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

    FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch